Highly  	Highly  	 RB	O
specific  	specific  	 JJ	O
ubiquitin-competing  	ubiquitin-competing  	 JJ	B-NP
molecules  	molecules  	 NNS	I-NP
effectively  	effectively  	 RB	O
promote  	promote  	 VB	O
frataxin  	frataxin  	 JJ	B-NP
accumulation  	accumulation  	 NN	I-NP
and  	and  	 CC	O
partially  	partially  	 RB	O
rescue  	rescue  	 VB	O
the  	the  	 DT	O
aconitase  	aconitase  	 JJ	B-NP
defect  	defect  	 NN	I-NP
in  	in  	 IN	O
Friedreich  	Friedreich  	 NNP	B-NP
ataxia  	ataxia  	 FW	I-NP
cells  	cells  	 FW	I-NP
Friedreich  	Friedreich  	 FW	I-NP
ataxia  	ataxia  	 FW	I-NP
is  	is  	 VBZ	O
an  	an  	 DT	O
inherited  	inherited  	 JJ	O
neurodegenerative  	neurodegenerative  	 JJ	B-NP
disease  	disease  	 NN	I-NP
that  	that  	 WDT	O
leads  	leads  	 VBZ	O
to  	to  	 TO	O
progressive  	progressive  	 JJ	B-NP
disability 	disability 	 NN	I-NP
.  	.  	 .	O
There  	There  	 EX	O
is  	is  	 VBZ	O
currently  	currently  	 RB	O
no  	no  	 DT	O
effective  	effective  	 JJ	O
treatment  	treatment  	 NN	O
and  	and  	 CC	O
patients  	patients  	 NNS	O
die  	die  	 VBP	O
prematurely 	prematurely 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
underlying  	underlying  	 JJ	O
genetic  	genetic  	 JJ	B-NP
defect  	defect  	 NN	I-NP
leads  	leads  	 VBZ	O
to  	to  	 TO	O
reduced  	reduced  	 JJ	O
expression  	expression  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
mitochondrial  	mitochondrial  	 JJ	B-NP
protein  	protein  	 NN	I-NP
frataxin 	frataxin 	 NN	I-NP
.  	.  	 .	O
Frataxin  	Frataxin  	 FW	B-NP
insufficiency  	insufficiency  	 FW	I-NP
causes  	causes  	 FW	I-NP
mitochondrial  	mitochondrial  	 FW	I-NP
dysfunction  	dysfunction  	 FW	I-NP
and  	and  	 CC	O
ultimately  	ultimately  	 RB	O
cell  	cell  	 JJ	O
death 	death 	 NN	O
,  	,  	 ,	O
particularly  	particularly  	 RB	O
in  	in  	 IN	O
peripheral  	peripheral  	 JJ	B-NP
sensory  	sensory  	 JJ	I-NP
ganglia 	ganglia 	 NN	I-NP
.  	.  	 .	O
There  	There  	 EX	O
is  	is  	 VBZ	O
an  	an  	 DT	O
inverse  	inverse  	 JJ	B-NP
correlation  	correlation  	 NN	I-NP
between  	between  	 IN	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
residual  	residual  	 JJ	B-NP
frataxin  	frataxin  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
severity  	severity  	 NN	O
of  	of  	 IN	O
disease  	disease  	 NN	B-NP
progression 	progression 	 NNS	I-NP
;  	;  	 :	O
therefore 	therefore 	 RB	O
,  	,  	 ,	O
therapeutic  	therapeutic  	 JJ	B-NP
approaches  	approaches  	 NNS	I-NP
aiming  	aiming  	 VBG	O
at  	at  	 IN	O
increasing  	increasing  	 VBG	O
frataxin  	frataxin  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
are  	are  	 VBP	O
expected  	expected  	 VBN	O
to  	to  	 TO	O
improve  	improve  	 VB	O
patients 	patients 	 NNS	O
'  	'  	 POS	O
conditions 	conditions 	 NNS	O
.  	.  	 .	O
We  	We  	 PRP	O
previously  	previously  	 RB	O
discovered  	discovered  	 VBN	O
that  	that  	 IN	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
frataxin  	frataxin  	 JJ	B-NP
precursor  	precursor  	 NN	I-NP
is  	is  	 VBZ	O
degraded  	degraded  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
ubiquitin 	ubiquitin 	 JJ	B-NP
/ 	/ 	 CD	I-NP
proteasome  	proteasome  	 JJ	I-NP
system  	system  	 NN	I-NP
before  	before  	 IN	O
its  	its  	 PRP$	O
functional  	functional  	 JJ	B-NP
mitochondrial  	mitochondrial  	 JJ	I-NP
maturation 	maturation 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
also  	also  	 RB	O
provided  	provided  	 VBN	B-NP
evidence  	evidence  	 NN	I-NP
for  	for  	 IN	I-NP
the  	the  	 DT	I-NP
therapeutic  	therapeutic  	 JJ	I-NP
potential  	potential  	 NN	I-NP
of  	of  	 IN	O
small  	small  	 JJ	O
molecules  	molecules  	 NNS	O
that  	that  	 IN	O
increase  	increase  	 NN	B-NP
frataxin  	frataxin  	 NN	I-NP
levels  	levels  	 NNS	I-NP
by  	by  	 IN	O
docking  	docking  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
frataxin  	frataxin  	 JJ	B-NP
ubiquitination  	ubiquitination  	 JJ	I-NP
site 	site 	 NN	I-NP
,  	,  	 ,	O
thus  	thus  	 RB	O
preventing  	preventing  	 VBG	O
frataxin  	frataxin  	 JJ	B-NP
ubiquitination  	ubiquitination  	 NN	I-NP
and  	and  	 CC	O
degradation 	degradation 	 NN	O
.  	.  	 .	O
We  	We  	 PRP	O
called  	called  	 VBD	O
these  	these  	 DT	O
compounds  	compounds  	 JJ	O
ubiquitin-competing  	ubiquitin-competing  	 JJ	B-NP
molecules  	molecules  	 NNS	I-NP
( 	( 	 -LRB-	O
UCM 	UCM 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
By  	By  	 IN	O
extending  	extending  	 VBG	O
our  	our  	 PRP$	O
search  	search  	 NN	O
for  	for  	 IN	O
effective  	effective  	 JJ	O
UCM 	UCM 	 NNP	B-NP
,  	,  	 ,	O
we  	we  	 PRP	O
identified  	identified  	 VBD	O
a  	a  	 DT	O
set  	set  	 NN	O
of  	of  	 IN	O
new  	new  	 JJ	O
and  	and  	 CC	O
more  	more  	 RBR	O
potent  	potent  	 JJ	O
compounds  	compounds  	 NN	O
that  	that  	 IN	O
more  	more  	 RBR	O
efficiently  	efficiently  	 RB	O
promote  	promote  	 VB	O
frataxin  	frataxin  	 JJ	B-NP
accumulation 	accumulation 	 NN	I-NP
.  	.  	 .	O
Here  	Here  	 RB	O
we  	we  	 PRP	O
show  	show  	 VBP	O
that  	that  	 IN	O
these  	these  	 DT	O
compounds  	compounds  	 NN	O
directly  	directly  	 RB	O
interact  	interact  	 VBN	O
with  	with  	 IN	O
frataxin  	frataxin  	 NN	B-NP
and  	and  	 CC	O
prevent  	prevent  	 VB	O
its  	its  	 PRP$	O
ubiquitination 	ubiquitination 	 NN	B-NP
.  	.  	 .	O
Interestingly 	Interestingly 	 RB	O
,  	,  	 ,	O
these  	these  	 DT	O
UCM  	UCM  	 NNP	B-NP
are  	are  	 VBP	O
not  	not  	 RB	O
effective  	effective  	 JJ	O
on  	on  	 IN	O
the  	the  	 DT	O
ubiquitin-resistant  	ubiquitin-resistant  	 JJ	B-NP
frataxin  	frataxin  	 JJ	I-NP
mutant 	mutant 	 NN	I-NP
,  	,  	 ,	O
indicating  	indicating  	 VBG	O
their  	their  	 PRP$	O
specific  	specific  	 JJ	O
action  	action  	 NN	O
on  	on  	 IN	O
preventing  	preventing  	 VBG	O
frataxin  	frataxin  	 JJ	B-NP
ubiquitination 	ubiquitination 	 NN	I-NP
.  	.  	 .	O
Most  	Most  	 RBS	O
importantly 	importantly 	 RB	O
,  	,  	 ,	O
these  	these  	 DT	O
compounds  	compounds  	 NNS	O
are  	are  	 VBP	O
able  	able  	 JJ	O
to  	to  	 TO	O
promote  	promote  	 VB	O
frataxin  	frataxin  	 JJ	B-NP
accumulation  	accumulation  	 NN	I-NP
and  	and  	 CC	O
aconitase  	aconitase  	 JJ	B-NP
rescue  	rescue  	 NN	I-NP
in  	in  	 IN	O
cells  	cells  	 NNS	O
derived  	derived  	 VBN	O
from  	from  	 IN	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
strongly  	strongly  	 RB	O
supporting  	supporting  	 VBG	O
their  	their  	 PRP$	O
therapeutic  	therapeutic  	 JJ	B-NP
potential 	potential 	 NN	I-NP
.  	.  	 .	O
